Evidence map›Paper›PMID 41704123›Full record

ArticleInfection control and hospital epidemiology2026

Current infection control practices for multidrug-resistant organisms (MDRO): a survey of the Society for Healthcare Epidemiology of America (SHEA) research network and affiliated US-based hospitals.

K C Coffey, Trudy Grossman, David B Banach, Anthony D Harris, David C Hooper, Susan S Huang, Erica S Shenoy

Abstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

K C CoffeyMassachusetts General Hospital and Harvard Medical Schoolhttps://ror.org/002pd6e78, Boston, MA, USA.ORCID https://orcid.org/0009-0003-1548-7202
Trudy GrossmanCombating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), USA.ORCID https://orcid.org/0009-0007-4569-0454
David B BanachUniversity of Connecticut School of Medicine, USA.ORCID https://orcid.org/0000-0003-4429-7750
Anthony D HarrisUniversity of Maryland School of Medicine, USA.
David C HooperMassachusetts General Hospital and Harvard Medical Schoolhttps://ror.org/002pd6e78, Boston, MA, USA.ORCID https://orcid.org/0000-0002-1444-9939
Susan S HuangUniversity of California Irvine School of Medicine, USA.ORCID https://orcid.org/0000-0001-6748-3447
Erica S ShenoyMassachusetts General Hospital and Harvard Medical Schoolhttps://ror.org/002pd6e78, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo understand current practices for screening, implementing and clearing contact precautions (CP) for multidrug-resistant organisms (MDRO).

designA survey of US-based SHEA Research Network (SRN) members and Community Healthcare Epidemiologists and Stewards (CHES).

participantsThe SRN is a consortium of healthcare facilities collaborating on multicenter research projects. CHES is an SRN-affiliated group of community hospital epidemiologists.

methodsA Research Electronic Data Capture (REDCap) survey was administered between January 7, 2025 and February 25, 2025. Frequencies and proportions were calculated in REDCap and Microsoft Excel. Fisher's exact and

resultsOf 134 facilities, 60 (45%) responded; 4 answered only demographic questions and were excluded from analysis. Most facilities (70%) performed active surveillance for ≥1 MDRO, but only 16% employed preemptive CP. All respondents reported using CP for ≥1 MDRO. CP were employed more often for infection than colonization. Clearance protocols to discontinue CP were common for MRSA (97%),

conclusionsInfection control practices varied by infection, colonization, specific MDRO, and time to clearance. Variation may indicate need for more data on transmission risk by disease state, organism, and time. Evidence-based strategies are needed to guide MDRO prioritization and CP duration and clearance policies. Guidance should acknowledge limitations in adherence, availability of private rooms, and persistent environmental reservoirs as major barriers to MDRO containment identified in this survey.

Identifiers

PMID41704123
PMCPMC13216800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.